4.6 Review

Indications, Limitations, and Development of Tricuspid Valve Interventions in Adults

期刊

CANADIAN JOURNAL OF CARDIOLOGY
卷 38, 期 10, 页码 S66-S78

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cjca.2021.08.013

关键词

-

资金

  1. Montreal Heart Institute

向作者/读者索取更多资源

Tricuspid regurgitation is associated with increased mortality and poor outcomes. There is a lack of sufficient treatment for tricuspid valve diseases. Transcatheter tricuspid valve interventions have emerged as a minimally invasive approach. Short-term results are satisfactory, but durability of the intervention needs to be considered.
Tricuspid regurgitation is associated with excessive mortality and poor outcomes regardless of the cause and associated comorbidities. Despite this clear association with mortality, tricuspid valve diseases remain undertreated. Tricuspid valve surgery, either repair or replacement, has shown little detectable survival benefit. Transcatheter tricuspid valve interventions have emerged as a less invasive approach to tricuspid valve diseases. They can be categorised into coaptation devices, annuloplasty devices, transcatheter tricuspid valve replacement, heterotopic caval valve implantation, and tricuspid valve-invalve. Despite the late referral and the patient's profile, results remain fairly acceptable at least in the short term, with good procedural device success, excellent safety profile, and sustained reduction of tricuspid regurgitation for up to 1 year. Because results are limited to the mid-term, transcatheter tricuspid valve intervention durability will need to be established before broader adoption of these technologies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据